Just over 4,200 people could be set to benefit after Sparsentan (also known as Filspari and made by Vifor Pharma) was recommended in final draft guidance as an option for treating primary ...

The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

Realizing their options for medically assisted death are so far limited in New York, a Catskills couple decided to seek it in Oregon.

The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.

Learn the signs of pancreatic cancer including unexplained weight loss, distinctive pain patterns, digestive changes, and ...

The Crossroads Center is set to move to a new 29,000-square-foot facility on Reading Road, expanding its mental health and addiction recovery services.

Up to 40% of all epilepsy diagnoses in the United States are of the drug-resistant variety, affecting 1.2 million people ...

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...

In light of former President Biden's prostate cancer diagnosis, retired journalist Jim Ware details his own journey.

The American Cancer Society reports about 1 in 8 men will be diagnosed with prostate cancer during their lifetime and there’s estimated to be more than 300,000 new cases of prostate cancer ...

The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...